Healthy Volunteers Clinical Trial
Official title:
The Effects of Intragastric Administration of Nutrients on Executive Control in Healthy Subjects.
| Verified date | November 2016 |
| Source | Universitaire Ziekenhuizen Leuven |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The previous research by one of our members in the research team (H. Miller) suggests a
possible influence of oral nutrients intake of certain fat or carbohydrates (glucose,
fructose) on executive control. On the other hand, another previous study from our group (L.
Van Oudenhove) suggests a subliminal influence of intragastric administration of fatty acids
on subjective and neural responses to negative emotion induction. The purpose of this study
therefore is to examine the effect of intragastric administration of certain fatty acids and
carbohydrates on executive control in healthy volunteers.
Therefore one group of healthy volunteers are invited to the study. The participants will be
randomly administered one of the three fatty acid emulsions or placebo via a nasogastric tube
in each of the visits. After the exposure period, participants will use a computer to perform
there different tasks to measure executive control. During each study visit, regular
measurements of emotion, physical sensations, as well as blood glucose will be assessed.
Furthermore, an electrocardiogram will be continuously recorded for the calculation of vagal
function.
| Status | Completed |
| Enrollment | 26 |
| Est. completion date | June 27, 2017 |
| Est. primary completion date | June 27, 2017 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 17 Years and older |
| Eligibility |
Inclusion Criteria: - N = 26 These numbers are based on a power calculation for a repeated measures ANOVA with one within-subject factor using Gpower software version 3.1.7 (http://www.psycho.uni-duesseldorf.de/abteilungen/aap/gpower3), indicating that these sample sizes are needed to achieve 90% power to detect a medium-sized effect (f = 0.25). - Men & women - Age: >17 years - 20 = BMI = 25 - Of good mental and physical health Exclusion Criteria: Participants with one or more of self-reported points below will be excluded: 1. History of, or current presence of: - Psychiatric disorders (e.g., anxiety disorders, somatization disorder, eating disorders, depression, substance-related disorders alcohol abuse or dependence etc.) - Abnormal eating behavior (including restraint and emotional eating) - Abdominal/thoracic surgery - Neurological, endocrine or digestive related disorders - Head trauma with loss of consciousness - Other serious medical conditions - Use of any drugs, including cannabis, during the past 6 months 2. Current presence of: - Pregnancy - Medication use that affects the function of the gastrointestinal tract and/or affects the nervous system, psychotropics or painkillers - A recent accident or surgery that has not fully recovered 3. Other - Smoking - Women not taking hormonal contraception |
| Country | Name | City | State |
|---|---|---|---|
| Belgium | University Hospitals Leuven, campus Gasthuisberg | Leuven |
| Lead Sponsor | Collaborator |
|---|---|
| Universitaire Ziekenhuizen Leuven | Katholieke Universiteit Leuven |
Belgium,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | trial making task | Participants will be required to connect a set of 25 numbered dots in numerical order as fast as possible while still maintaining accuracy. | 60 min after intervention | |
| Primary | digital span task | Participants will be presented with a series of single-digit numbers and required to remember them. After the series has been presented the participants will need to indicate the numbers presented. | 60 min after intervention | |
| Primary | memory task | A list of 15 words that are matched for frequency, concreteness, and imagery will be presented to the participant via a computer monitor at the rate of one every 2 sec. Afterwards they will be given 60 sec to write down as many words as they are able to recall from the list. Accuracy and errors will be recorded. | 60 min after intervention |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |